PPIE Award: Recognising patient and public involvement in cell and gene therapy development Introduction Including patient and public involvement in research studies and the development process of new therapies is recognised as good practice. The National institute for Health Research…
Abstract Submission The main text of the abstract has a 250 words limit. The title, authors and affiliations are not counted in that word limit. Choose to submit as poster only, oral only, either poster or oral. Category choices :…
Biography: I am a pharmacy student at University College London with a strong interest in molecular biology and neuropharmacology. My studies have deepened my appreciation of how drugs interact with biological systems, particularly how substrates modulate cell signalling pathways to…
Biography: Casey is a 4th year MSci Biochemistry (Molecular Biology) with a Year in Industry student at University College London (UCL). She completed her URB project with Dr. Amanda Carr and Ana Alonso-Carriazo Fernandez at the UCL Institute of Ophthalmology…
Join the Board BSGCT Board members serve a three year term and may be re elected for a further three years. Early Career Representatives serve for two years and may be re elected for a further two years, contributing an…
Gene-ious at Work: Editing the Future for Patients with Sickle Cell Disease By Lucy Williams, PhD student at Cardiff University and runner-up of the BSGCT Scientific Writing Competition. Lucy's research focuses on the development of a precise virus-based cancer therapy that…
The BSGCT Mentoring Programme aims to partner an aspiring early career gene and cell therapy scientist, with a more senior member of the BSGCT board acting as a mentor. These mentee-led partnerships meet several times over a six-month period to…
After the Window Closes: The New Hope for Neurodevelopmental Disorders By Ouidad Khechaoui, PhD researcher in neurodevelopmental AAV Gene Therapy at the University of Sheffield When the parents of a child with a neurodevelopmental disorder first hear the diagnosis, they…
We are delighted to introduce the current and newly appointed members of the BSGCT Board. We are grateful to our existing Board members for their continued commitment and warmly welcome the new members joining us as we work together to…
From Lab to Clinic: The Science Behind Safer Stem Cell Therapies Imagine a future where damaged organs are repaired, blindness is reversed, and Parkinson’s disease treated. Sounds like science fiction? It’s not! Current advancements in regenerative medicine are getting us…